Literature DB >> 21347118

Facilitating Clinical Research through the Health Information Exchange: Lipid Control as an Example.

Vivienne J Zhu1, Wanzhu Tu, Marc B Rosenman, J Marc Overhage.   

Abstract

Using data from the Indiana Network of Patient Care (INPC), we analyzed long-term statin adherence patterns and their effects on low-density lipoprotein cholesterol (LDL-C) control among patients with type 2 diabetes. Statin adherence was measured by proportion of days covered (PDC) for a 6-month interval prior to each LDL-C test date. Patient demographic and clinical characteristics were used as covariates for LDL-C control and predictors for statin adherence. From 4,350 eligible subjects, 25,596 6-month PDC and LDL-C level pairs were formed between 2001 and 2009. Rates of suboptimal adherence and suboptimal LDL-C control were 68.5% and 46.6%, respectively. Positive predictors for LDL-C control included adherence to statin (OR: 1.87, p<0.0001) and older age (OR: 1.11, p=0.01). Significant risk factors for non-adherence were young age, female gender, African American race and newly-treated status. This study demonstrated the utility of a health information exchange in health outcome and clinical effectiveness research.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21347118      PMCID: PMC3041406     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  20 in total

1.  Widespread statin use recommended for patients with type 2 diabetes.

Authors:  Rebecca Voelker
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

2.  Communities' readiness for health information exchange: the National Landscape in 2004.

Authors:  J Marc Overhage; Lori Evans; Janet Marchibroda
Journal:  J Am Med Inform Assoc       Date:  2004-11-23       Impact factor: 4.497

3.  Comparative effectiveness research: a report from the Institute of Medicine.

Authors:  Harold C Sox; Sheldon Greenfield
Journal:  Ann Intern Med       Date:  2009-06-30       Impact factor: 25.391

Review 4.  The assessment of refill compliance using pharmacy records: methods, validity, and applications.

Authors:  J F Steiner; A V Prochazka
Journal:  J Clin Epidemiol       Date:  1997-01       Impact factor: 6.437

5.  Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia.

Authors:  Herve Caspard; Arnold K Chan; Alexander M Walker
Journal:  Clin Ther       Date:  2005-10       Impact factor: 3.393

6.  Association between adherence to statin therapy and lipid control in Hong Kong Chinese patients at high risk of coronary heart disease.

Authors:  Caroline W R Cheng; Kam-Sang Woo; Juliana C N Chan; Brian Tomlinson; Joyce H S You
Journal:  Br J Clin Pharmacol       Date:  2004-11       Impact factor: 4.335

7.  Adherence with statin therapy in elderly patients with and without acute coronary syndromes.

Authors:  Cynthia A Jackevicius; Muhammad Mamdani; Jack V Tu
Journal:  JAMA       Date:  2002 Jul 24-31       Impact factor: 56.272

8.  Long-term persistence in use of statin therapy in elderly patients.

Authors:  Joshua S Benner; Robert J Glynn; Helen Mogun; Peter J Neumann; Milton C Weinstein; Jerry Avorn
Journal:  JAMA       Date:  2002 Jul 24-31       Impact factor: 56.272

9.  Comparison of methods to assess medication adherence and classify nonadherence.

Authors:  Richard A Hansen; Mimi M Kim; Liping Song; Wanzhu Tu; Jingwei Wu; Michael D Murray
Journal:  Ann Pharmacother       Date:  2009-03-03       Impact factor: 3.154

10.  Adequacy of glycemic, lipid, and blood pressure management for patients with diabetes in a managed care setting.

Authors:  Sarah J Beaton; Soma S Nag; Margaret J Gunter; Jeremy M Gleeson; Shiva S Sajjan; Charles M Alexander
Journal:  Diabetes Care       Date:  2004-03       Impact factor: 19.112

View more
  6 in total

1.  Race and medication adherence and glycemic control: findings from an operational health information exchange.

Authors:  Vivienne J Zhu; Wanzhu Tu; David G Marrero; Marc B Rosenman; J Marc Overhage
Journal:  AMIA Annu Symp Proc       Date:  2011-10-22

Review 2.  Glucose control in diabetes: the impact of racial differences on monitoring and outcomes.

Authors:  Jennifer A Campbell; Rebekah J Walker; Brittany L Smalls; Leonard E Egede
Journal:  Endocrine       Date:  2012-07-20       Impact factor: 3.633

3.  A survey of informatics platforms that enable distributed comparative effectiveness research using multi-institutional heterogenous clinical data.

Authors:  Dean F Sittig; Brian L Hazlehurst; Jeffrey Brown; Shawn Murphy; Marc Rosenman; Peter Tarczy-Hornoch; Adam B Wilcox
Journal:  Med Care       Date:  2012-07       Impact factor: 2.983

4.  Diabetes and asthma case identification, validation, and representativeness when using electronic health data to construct registries for comparative effectiveness and epidemiologic research.

Authors:  Jay R Desai; Pingsheng Wu; Greg A Nichols; Tracy A Lieu; Patrick J O'Connor
Journal:  Med Care       Date:  2012-07       Impact factor: 2.983

Review 5.  Influence of Race, Ethnicity and Social Determinants of Health on Diabetes Outcomes.

Authors:  Rebekah J Walker; Joni Strom Williams; Leonard E Egede
Journal:  Am J Med Sci       Date:  2016-04       Impact factor: 2.378

6.  Integration of Provider, Pharmacy, and Patient-Reported Data to Improve Medication Adherence for Type 2 Diabetes: A Controlled Before-After Pilot Study.

Authors:  Brian E Dixon; Abdullah H Alzeer; Erin O'Kelly Phillips; David G Marrero
Journal:  JMIR Med Inform       Date:  2016-02-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.